ABLAZE PHARMACEUTICALS
Ablaze Pharma is a clinical stage bio-pharmaceutical company that is focused on developing Targeted Radiotherapy (TRT) to benefit cancer patients.
ABLAZE PHARMACEUTICALS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2011-04-01
Address:
Jingan, Shanghai, China
Country:
China
Website Url:
http://www.ablazepharma.com
Status:
Active
Total Funding:
75 M USD
Technology used in webpage:
Microsoft Exchange Online Office 365 Mail
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Nan Fung Life Sciences
Nan Fung Life Sciences investment in Series A - Ablaze Pharmaceuticals
Vivo Capital
Vivo Capital investment in Series A - Ablaze Pharmaceuticals
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series A - Ablaze Pharmaceuticals
Pivotal bioVenture Partners China
Pivotal bioVenture Partners China investment in Series A - Ablaze Pharmaceuticals
Samsara BioCapital
Samsara BioCapital investment in Series A - Ablaze Pharmaceuticals
Advantech Capital
Advantech Capital investment in Series A - Ablaze Pharmaceuticals
venBio Partners
venBio Partners investment in Series A - Ablaze Pharmaceuticals
RAYZ Investments
RAYZ Investments investment in Series A - Ablaze Pharmaceuticals
Official Site Inspections
http://www.ablazepharma.com Semrush global rank: 5.95 M Semrush visits lastest month: 1.38 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Ablaze Pharmaceuticals"
Ablaze Pharmaceuticals (US) - life-sciences-usa.com
Jan 1, 2021 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) France Biotech; Life Science Washington; Virginia Biotechnology Organisation …See details»
Ablaze Pharmaceuticals - Crunchbase Company Profile …
Organization. Ablaze Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
Ablaze Pharmaceuticals - LinkedIn
Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company with a mission to bring advanced targeted radiopharmaceutical therapies (TRT) to benefit cancer patients in China.See details»
Ablaze Pharmaceuticals: Contact Details and Business Profile
Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company with a mission to bring advanced targeted radiopharmaceutical therapies (TRT) to benefit cancer patients in China.See details»
艾博兹医药
艾博兹医药See details»
Ablaze Pharmaceuticals. (11/29/21). "Press Release: Ablaze ...
Leveraging its team’s extensive business experience and network in cross-border product development and deal making, Ablaze strives to become the leader and the partner of choice …See details»
Ablaze Pharmaceuticals - Craft
Ablaze Pharmaceuticals is a pharmaceutical company developing targeted radiotherapy against tumor targets. It is focused on radiopharmaceuticals, the same drug conjugate of which can be …See details»
Ablaze Pharmaceuticals | Startup Profile and Investments
Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company founded in 2011 with a mission to revolutionize the targeted radiotherapy landscape in China. The company has …See details»
Ablaze Pharmaceuticals (艾博兹医药（上海）有限公司) - 药物管 …
凭借其团队在跨境产品开发和交易方面的丰富经验和网络，艾博兹医药致力于通过和国内外战略伙伴的合作，成为中国新兴的TRT市场领导者和首选合作伙伴。欲了解更多信息，欢迎访问 …See details»
Ablaze Pharmaceuticals - PitchBook
Ablaze Pharmaceuticals General Information Description. Developer of Targeted Radiotherapy (TRT) Treatments based on clinical stage. The company leverages founders' extensive business experience and network in cross-border product …See details»
Ablaze Pharmaceuticals - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Ablaze Pharmaceuticals Shanghai Co., Ltd. - life-sciences-asia.com
Jan 1, 2021 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) ASMS (American Society for Mass Spectrometry) Israel Life Science Industry …See details»
艾博兹医药-动脉网 - vbdata.cn
Apr 30, 2021 艾博兹医药是一家临床阶段的生物制药公司，专注于开发靶向同位素治疗 (trt) 产品以造福中国的癌症患者。我们将借助公司创始人在跨境药品开发和交易方面有丰富业务经验和 …See details»
Ablaze Pharmaceuticals Launches with $75m Series A Financing to …
Nov 29, 2021 For more information, please visit www.ablazepharma.com. About Vivo Capital. Founded in 1996, Vivo Capital is a global investment firm focused on healthcare.See details»
Ablaze Pharmaceuticals_艾博兹医药（上海）有限公司_亿欧数据
Apr 30, 2021 亿欧数据为您提供艾博兹医药（上海）有限公司的主营业务、公司简介、企业官网、公司地址、招聘信息、财务信息、融资情况、团队信息、电话号码、招投标信息、专利等多 …See details»
艾博兹医药：硬“核”创新，引领靶向治疗新篇章（一文详解）医药 …
Sep 14, 2024 艾博兹医药成立于2021年，在上海、北京、成都三地设有办公室 ，秉持 “为中国患者提供创新且可及的靶向放射治疗药物” 为自身使命，致力于通过持续创新，提供安全、有效 …See details»
Ablaze Pharmaceuticals Plans Development of Innovative GPC3 …
Ablaze Pharma Mar 31, 2023, 10:00 ET. Share this article. Share to X. Share this article. Share to X. SHANGHAI, March 31, 2023 /PRNewswire/ -- Ablaze Pharmaceuticals, a biotech company …See details»
Ablaze Pharmaceuticals - Overview, News & Similar companies
Dec 25, 2022 Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China SHANGHAI, March 31, 2023 …See details»
Ablaze Pharmaceuticals - Products, Competitors, Financials, …
Oct 23, 2023 For more information, please visit www.ablazepharma.com. Oct 23, 2023. Eckert & Ziegler to Supply Ablaze Pharmaceuticals with Lutetium-177 for Clinical Trials. Apr 3, 2023. …See details»
Trump tariff news: Canada exempt from reciprocal tariffs
Apr 9, 2025 The White House has confirmed to CTV News that Canada is exempt from the 10 per cent baseline reciprocal tariffs it’s imposing on dozens of other countries.See details»